Veeva Announces Clinical Study Training Application
Veeva Systems recently introduced Veeva Vault Study Training, a new application designed to unify learning management and clinical operations for enhanced clinical study training. This platform allows research sites, CROs, and sponsors to train trial staff efficiently and maintain real-time inspection readiness by automating training certificate filing. The application, available to early adopters in fall 2022, aims to streamline study execution and compliance, leveraging existing clinical data to minimize redundancy and manual tasks.
- Launch of Veeva Vault Study Training that targets efficiency in clinical study training.
- Integration of existing data improves compliance and operational efficiency.
- Available to early adopters in fall 2022, indicating a timely market entry.
- Veeva Vault Study Training is still in early adoption phase and may face initial user challenges.
Veeva Vault Study Training unifies learning management and clinical operations for integrated and automated training and real-time inspection readiness
PLEASANTON, Calif., June 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Study Training, a new application that brings together research sites, CROs, and sponsors into a single platform for end-to-end clinical study training. Organizations using Vault Study Training can ensure all trial staff are qualified within required timelines while automating the filing of training certificates into Veeva Vault eTMF for real-time inspection readiness.
"Veeva continues to collaborate closely with the industry to identify gaps in key processes across clinical development and deliver innovations that can improve operational efficiency," said Ed Leftin, director, information technology at Ora, Inc. "The ability to use existing data and content in Veeva Vault Clinical Suite to create training, from study start to conduct, can streamline study execution and improve compliance."
Vault Study Training builds on Veeva's experience working with more than 450 companies using Veeva Vault Clinical Suite applications and learnings from hundreds of Veeva Vault Training implementations. Life sciences companies can now address the long-standing industry challenge of training study staff and site personnel in an efficient and compliant way.
Veeva's complete and connected solution will allow life sciences companies to leverage current clinical master data and content to remove issues like redundant information, manual data entry, and siloed processes. Vault Study Training automates assignment distribution, protocol amendment management, and training certificate filing for increased efficiency and reduced end of study reconciliation.
"As studies evolve and reach new levels of complexity, companies need a streamlined and integrated training system that can scale with the demands of today's trials," said Shad Ayoub, senior director, Veeva Vault Study Training. "Veeva Vault Study Training will deliver a fundamentally better experience to sites, CROs, and sponsors."
Vault Study Training will be available to early adopters in fall 2022. To learn more about Vault Study Training, visit veeva.com/VaultStudyTraining.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2022, which you can find here (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov.
Contact: | |
Deivis Mercado | Jeremy Whittaker +49 6950955486 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-clinical-study-training-application-301562504.html
SOURCE Veeva Systems
FAQ
What is Veeva Vault Study Training?
When will Veeva Vault Study Training be available?
How does Veeva Vault Study Training improve compliance?
What are the benefits of using Veeva Vault Study Training?
What companies can benefit from Veeva Vault Study Training?
